Yildirim, B., Sabir, N., & Kaleli, B. (2003). Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertility and Sterility, 79(6), 1358-1364. https://doi.org/10.1016/s0015-0282(03)00265-6
Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003;79(6):1358-1364. doi:10.1016/s0015-0282(03)00265-6
Yildirim, Basak, et al. "Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome." Fertility and Sterility, vol. 79, no. 6, 2003, pp. 1358-1364.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Free to read at the publisher (reported by Unpaywall and OpenAlex, not verified by RRM Academy)
Author affiliations
2 institutions
Department of Obstetrics and Gynecology, Faculty of Medicine, Pamukkale University, Denizli, Turkey. basakyildirim@hotmail.com
Lean women with PCOS carry more visceral fat than controls
Lean women with PCOS (also called PMOS, Polyendocrine Metabolic Ovarian Syndrome) had thicker visceral and preperitoneal fat than lean controls on ultrasound. The case-control study included 30 women per group. Among the women with PCOS, thicker visceral fat went with higher triglycerides and fasting insulin.
Key Findings
Visceral fat thickness averaged 16.7 mm in the PCOS group and 9.4 mm in controls (P = .0001); preperitoneal fat averaged 8.3 mm and 4.9 mm (P = .0001).
Subcutaneous fat thickness was similar between groups: 10.3 mm with PCOS and 8.9 mm in controls (not significant).
Insulin area under the curve during the glucose tolerance test was significantly higher with PCOS than in controls (P < .001). It correlated with visceral fat thickness (r = .573).
Among the women with PCOS, regression showed visceral fat thickness contributing to both triglycerides (P < .0001) and fasting insulin (P < .0001).
Interpretation
The study is a prospective case-control comparison of 30 lean women with PCOS and 30 lean controls at one university hospital in Turkey. All had a body mass index under 25, so the findings describe lean women. Ultrasound measured fat thickness at set abdominal sites. In the women with PCOS, visceral and preperitoneal fat thickness correlated with triglycerides, HDL cholesterol and insulin measures, and subcutaneous fat thickness showed no such correlation. The authors propose visceral fat as a possible early marker of metabolic disorders in lean women with PCOS.
RRM Context
Restorative reproductive medicine treats PCOS as both a metabolic and an ovulation problem. The lean women here still had significantly higher insulin than controls, so a normal weight does not settle the metabolic questions. A cause-based workup checks them alongside the cycle chart.
Our editorial summary of this paper, not the article's abstract.
Abstract
Objective
To investigate the relation between intra-abdominal fat distribution and metabolic disorders in nonobese patients with the polycystic ovary syndrome (PCOS).
Design
Prospective case-control study.
Setting
University-based hospital.
Patients
Thirty nonobese patients with PCOS and 30 lean women with regular menstrual cycles (controls). All participants had a body mass index < 25kg/m(2).
Main Outcome Measures
Subcutaneous and intra-abdominal visceral and preperitoneal fat thicknesses were assessed by ultrasonography. Glucose tolerance and insulin sensitivity were evaluated by standard 75-g oral glucose tolerance test and area-under-the-curve analysis. Serum hormones and lipid profile were measured.
Results
The mean preperitoneal and visceral fat thicknesses were significantly greater in nonobese patients with PCOS. Subcutaneous fat mass was similar between the PCOS and control groups. Nonobese patients with PCOS had glucose intolerance, hyperinsulinemia, and dyslipidemia, manifested by high serum levels of triglyceride, total cholesterol, and high-density lipoprotein (HDL) levels and low serum low-density lipoprotein (LDL) levels. No correlation existed between subcutaneous fat thickness and the metabolic variables in nonobese patients with PCOS. However, serum triglyceride levels correlated with visceral fat and preperitoneal fat thickness. The mean HDL level correlated negatively with visceral fat and preperitoneal fat thickness. The area under the curve for insulin and mean fasting insulin levels correlated positively with visceral fat thickness. In multiple regression analysis, visceral fat thickness contributed significantly to high serum triglyceride and fasting insulin levels.
Conclusions
Intra-abdominal preperitoneal and visceral fat accumulation may contribute to the development of glucose and lipid metabolism disorders in nonobese patients with PCOS.
PMOS / PCOS has four diagnostic phenotypes and distinct metabolic, reproductive, and mental health implications. How RRM-trained clinicians approach diagnosis and treatment differently.